Eli Lilly and Company's Fiscal Year is From January To December.
The item "Payables-Turnover" stands at 3.56 as of 06/30/2026, the lowest value since 03/31/2025.
As of the end of Eli Lilly and Company's second quarter, the item "Payables Turnover" stands at 3.56. This represents a decrease of -2.53 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -11.85 percent compared to the value the year prior.
The 1 year change in percent is -11.85.
The 3 year change in percent is -3.22.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Payables Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Payables Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Payables Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Payables Turnover | 280,205,508,085.11 |
![]() | Novartis AG - Payables Turnover | 255,096,620,580.91 |